[Skip to content]

Print this page

2.11 Antifibrinolytic drugs and haemostatics

Tranexamic acid tablets, injection


Tranexamic acid is included for the treatment of menorrhagia

Blood Products

Drotrecogin Alfa (activated) for severe sepsis in multiple organ failure has been withdrawn following results from the PROWESS-SHOCK study which failed to show significant reduction in 28-day all-case mortality in patients with septic shock.

For link to BNF section: 2.11 Antifibrinolytic drugs and haemostatics